The effect of using torniquets on fracture healing disorders: A study in wistar strain rats (Rattus norvegicus)

Application of chitosan with different molecular weights in cartilage tissue engineering

Cartilage tissue engineering involves the invention of novel implantable cartilage replacement materials to help heal cartilage injuries that do not heal themselves, aiming to overcome the shortcomings of current clinical cartilage treatments. Chitosan has been widely used in cartilage tissue engineering because of its similar structure to glycine aminoglycan, which is widely distributed in connective tissues. The molecular weight, as an important structural parameter of chitosan, affects not only the method of chitosan composite scaffold preparation but also the effect on cartilage tissue healing. Thus, this review identifies methods for the preparation of chitosan composite scaffolds with low, medium and high molecular weights, as well as a range of chitosan molecular weights appropriate for cartilage tissue repair, by summarizing the application of different molecular weights of chitosan in cartilage repair in recent years.

Preventing Ischemic-Reperfusion Injury after Tourniquet Application in Fracture using Aloe vera Ethanolic Extract

Introduction: A tourniquet is a typical equipment used in the orthopedics surgery to decrease blood loss and create a better operating environment. Ischemic-reperfusion damage, which happens when the tourniquet is deflated, is one of the tourniquet's negative effects. Antioxidants can be used to minimize oxidative stress, which is one strategy to mitigate ischemic-reperfusion injury. Aloe vera, for example, is widely known for its antioxidant and anti-inflammatory properties. Method: The tibias of male Wistar strain rats (Rattus norvegicus) were fractured in this experiment, and Aloe vera gel was given orally as an antioxidant. A total of 18 rats were utilized in this research, which were separated into 6 groups. Varying amounts of Aloe vera extract were given to the treatment groups: 40 mg/kgBW, 60 mg/kgBW, and 80 mg/kgBW. The tourniquet would be inflated for two hours then deflated after application of the Aloe vera extract. Superoxide dismutase (SOD) and malondialdehyde levels were measured in the tibia (MDA). Result: Application of tourniquet increased oxidative stress marker in fracture state, marked by reduction of SOD and increase of MDA. After administration of Aloe vera extract, the oxidative stress parameters (SOD and MDA) were reduced significantly. Conclusion: The result of this study suggests that tourniquet increased oxidative stress marker in fracture state and Aloe vera extract could be used to ameliorate this ischemic-reperfusion injury.

The risks associated with tourniquet use in lower limb trauma surgery: a systematic review and meta-analysis

Purpose

Tourniquet use in lower limb fracture surgery may reduce intra-operative bleeding, improve surgical field of view and reduce length of procedure. However, tourniquets may result in pain and the production of harmful metabolites cause complications or affect functional outcomes. This systematic review aimed to compare outcomes following lower limb fracture surgery performed with or without tourniquet.

Methods

We searched databases for RCTs comparing lower limb fracture surgery performed with versus without tourniquet reporting on outcomes pain, physical function, health-related quality of life, complications, cognitive function, blood loss, length of stay, length of procedure, swelling, time to union, surgical field of view, volume of anaesthetic agent, biochemical markers of inflammation and injury, and electrolyte and acid–base balance. Random-effects meta-analysis was performed. PROSPERO ID CRD42020209310.

Results

Six RCTs enabled inclusion of 552 procedures. Pooled analysis demonstrated that tourniquet use reduced length of procedure by 6 minutes (95% CI −10.12 to −1.87; p < 0.010). We were unable to exclude increased harms from tourniquet use. Pooled analysis showed post-operative pain score was higher in tourniquet group by 12.88 on 100-point scale (95% CI −1.25–27.02; p = 0.070). Risk differences for wound infection, deep venous thrombosis and re-operation were 0.06 (95% CI −0.00–0.12; p = 0.070), 0.05 (95% CI −0.02–0.11; p = 0.150) and 0.03 (95% CI -0.03–0.09; p = 0.340).

Conclusion

Tourniquet use was associated with a reduced length of procedure. It is possible that tourniquets also increase incidence of important complications, but the data are too sparse to draw firm conclusions. Methodological weaknesses of the included RCTs prevent any solid conclusions being drawn for outcomes investigated. Further studies are required to address these limitations.

Supplementary Information

The online version contains supplementary material available at 10.1007/s00590-021-02957-7.